tiprankstipranks
Advertisement
Advertisement

AU:AVE Stock Latest News

Avecho to Showcase CBD Insomnia Program at NWR Healthcare Conference
Company AnnouncementsAvecho to Showcase CBD Insomnia Program at NWR Healthcare Conference
17d ago
Avecho hits key Phase III recruitment milestone in CBD insomnia trial
PremiumCompany Announcements
Avecho hits key Phase III recruitment milestone in CBD insomnia trial
1M ago
Avecho Files Updated Corporate Governance Statement and Appendix 4G with ASX
PremiumCompany Announcements
Avecho Files Updated Corporate Governance Statement and Appendix 4G with ASX
1M ago
Avecho Widens Annual Loss Despite Higher Revenue as Development Spending Continues
PremiumCompany Announcements
Avecho Widens Annual Loss Despite Higher Revenue as Development Spending Continues
1M ago
Avecho nears key Phase III milestone as CEO showcases CBD insomnia program at healthcare forum
PremiumCompany Announcements
Avecho nears key Phase III milestone as CEO showcases CBD insomnia program at healthcare forum
2M ago
Avecho Advances Phase III CBD Insomnia Trial, Raises Capital and Secures US/EU Patent Wins
PremiumCompany AnnouncementsAvecho Advances Phase III CBD Insomnia Trial, Raises Capital and Secures US/EU Patent Wins
2M ago
Avecho Nears Completion of Recruitment for Phase III CBD Trial
Premium
Company Announcements
Avecho Nears Completion of Recruitment for Phase III CBD Trial
4M ago
Avecho Secures US and European Patent Allowances for CBD Soft-Gel Capsule
Premium
Company Announcements
Avecho Secures US and European Patent Allowances for CBD Soft-Gel Capsule
4M ago
Avecho Biotechnology Announces Quotation of 500 Million Securities on ASX
PremiumCompany Announcements
Avecho Biotechnology Announces Quotation of 500 Million Securities on ASX
5M ago
Avecho Biotechnology Expands Share Issuance to Boost Strategic Initiatives
PremiumCompany Announcements
Avecho Biotechnology Expands Share Issuance to Boost Strategic Initiatives
5M ago
Avecho Advances Phase III CBD Insomnia Trial with New Funding
PremiumCompany Announcements
Avecho Advances Phase III CBD Insomnia Trial with New Funding
5M ago
Avecho’s CBD Study: A Potential Game-Changer for Insomnia Treatment
PremiumCompany Announcements
Avecho’s CBD Study: A Potential Game-Changer for Insomnia Treatment
5M ago
AVE
Avecho Biotechnology Announces Proposed Issue of 20 Million Securities
PremiumCompany AnnouncementsAvecho Biotechnology Announces Proposed Issue of 20 Million Securities
6M ago
Avecho Biotechnology to Issue 500 Million New Securities
Premium
Company Announcements
Avecho Biotechnology to Issue 500 Million New Securities
6M ago
Avecho Biotechnology Secures $2.5M to Advance CBD Capsule Development
Premium
Company Announcements
Avecho Biotechnology Secures $2.5M to Advance CBD Capsule Development
6M ago
Avecho Biotechnology Advances Cannabidiol Product for Insomnia
PremiumCompany Announcements
Avecho Biotechnology Advances Cannabidiol Product for Insomnia
6M ago
Avecho Biotechnology Corrects Unquoted Options Issuance Figures
PremiumCompany Announcements
Avecho Biotechnology Corrects Unquoted Options Issuance Figures
6M ago
Avecho Biotechnology Sees Revenue Surge Amid Rising R&D Costs
PremiumCompany Announcements
Avecho Biotechnology Sees Revenue Surge Amid Rising R&D Costs
7M ago
Avecho Expands Insomnia Trial and Eyes First OTC CBD Product in Australia
PremiumCompany Announcements
Avecho Expands Insomnia Trial and Eyes First OTC CBD Product in Australia
8M ago
Avecho Advances Phase III Trial for CBD Insomnia Treatment
PremiumCompany AnnouncementsAvecho Advances Phase III Trial for CBD Insomnia Treatment
8M ago
Avecho Biotechnology Announces Change in Substantial Holder Interests
Premium
Company Announcements
Avecho Biotechnology Announces Change in Substantial Holder Interests
10M ago
Avecho Biotechnology Secures R&D Tax Incentive to Advance CBD Insomnia Treatment
Premium
Company Announcements
Avecho Biotechnology Secures R&D Tax Incentive to Advance CBD Insomnia Treatment
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >